🇺🇸 FDA
Pipeline program

Alofisel 5 × 106 cells/mL dispersion for injection.

Alofisel-4001

Approved small_molecule active

Quick answer

Alofisel 5 × 106 cells/mL dispersion for injection. for Perianal fistulising Crohn´s disease is a Approved program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Perianal fistulising Crohn´s disease
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials